In a report released yesterday, Whitney Ijem from Canaccord Genuity reiterated a Buy rating on Alnylam Pharma (ALNY – Research Report), with a ...

Fintel reports that on April 3, 2025, Canaccord Genuity initiated coverage of LifeStance Health Group (NasdaqGS:LFST) with a ...

Canaccord Genuity analyst George Gianarikas reiterated a Buy rating on ASP Isotopes, Inc. (ASPI – Research Report) yesterday and set a price ...

Fintel reports that on April 3, 2025, Canaccord Genuity initiated coverage of Talkspace (NasdaqCM:TALK) with a Buy recommendation. Analyst Price Forecast Suggests 82.80% Upside As of April 2, 2025, ...

Canaccord Genuity Group said Tuesday that it agreed to sell its U.S. wholesale market-making business as it looks to focus more on its investment-banking platform. The Toronto financial-services firm ...

LifeSpeak (TSE:LSPK – Get Free Report) had its price target dropped by equities researchers at Canaccord Genuity Group from ...

Cantor, a premier investment bank, today announced it has entered into a definitive agreement to acquire Canaccord Genuity Group's U.S.-based wholesale market making business, which specializes in U.S ...

Canaccord Genuity has established itself as a market leader in M&A advisory and equity capital markets across the technology, healthcare, sustainability, and consumer sectors. The Company's global ...

To join the virtual panel discussion, please contact your Canaccord Genuity conference representative. About Marker Therapeutics, Inc. Marker Therapeutics, Inc. is a Houston, TX-based clinical ...

Aeva Technologies (NASDAQ:AEVA) and Arbe Robotics (NASDAQ:ARBE) both received Buy ratings due to their potential roles in the ...

Analysts at Canaccord Genuity initiated coverage on transportation and logistics industry software provider Microlise at 'buy ...

This week’s episode features Canaccord Genuity senior investment advisor Cam Currie in conversation with host Adrian Pocobelli on the outlook for gold stocks. Currie shares his insights on gold and ...